The Valley Desk

NCT01471964 · Interventional trial

Study to Assess Safety and Tolerability of MLN8237, In Combination With Erlotinib to Treat Non-Small Cell Lung Cancer

Overall registry status Terminated

Phase 1 · Phase 2

Conditions Non-small Cell Lung Cancer Metastatic, Non-small Cell Lung Cancer Recurrent

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov